In 2023, the business enterprise R&D expenditure in the manufacture of irradiation, electromedical, and electrotherapeutic equipment in Japan was $842 million USD PPP. The forecasted data from 2024 to 2028 shows a gradual decline in expenditure, decreasing from $838 million USD PPP in 2024 to $830.83 million USD PPP in 2028. This represents a year-on-year reduction ranging between 0.2% and 0.3%. The CAGR over these five years reflects an average annual decrease of approximately 0.3%.

Future trends to watch for:

Technological innovations that could necessitate increased R&D spending despite current trends.
Government policies or incentives that might alter funding allocations significantly.
Global economic conditions influencing company budget allocations and priority shifts.